Prevalence of Antimicrobial Resistance in Gram-Negative Bacteria Bloodstream Infections in Peru and Associated Outcomes: VIRAPERU Study

Surveillance of antimicrobial resistance among gram-negative bacteria (GNB) is of critical importance, but data for Peru are not available. To fill this gap, a non-interventional hospital-based surveillance study was conducted in 15 hospitals across Peru from July 2017 to October 2019. Consecutive u...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of tropical medicine and hygiene 2023-11, Vol.109 (5), p.1095-1106
Hauptverfasser: Krapp, Fiorella, García, Coralith, Hinostroza, Noemi, Astocondor, Lizeth, Rondon, Claudia R, Ingelbeen, Brecht, Alpaca-Salvador, Hugo A, Amaro, Catherine, Aguado Ventura, Carla, Barco-Yaipén, Evelyn, Bocangel Fernandez, Cesar, Briones, Alexander, Burgos, Antonio, Campana, Rene, Castillo, Kelly, Castañeda-Sabogal, Alex, Coaquira, Angelica, Concha-Velasco, Fátima, Cuadros, Edwin Cuaresma, Chincha, Omayra, Diaz, Juan Carlos, Díaz Sipión, Roberto, Fernandez, Victor, Hueda-Zavaleta, Miguel, López, Enrique, Valera-Krumdieck, María, Vásquez, Rubén, Vidaurre Torres, Ana María, Villegas-Chiroque, Miguel, Sarmiento Lopez, Favio, Sullón Zavaleta, Pedro Alberto, Sierra Chavez, Elizett, Paricahua Peralta, Eduardo, Peralta Córdova, Teresa, Pino-Dueñas, Jimena Edith, Jacobs, Jan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1106
container_issue 5
container_start_page 1095
container_title The American journal of tropical medicine and hygiene
container_volume 109
creator Krapp, Fiorella
García, Coralith
Hinostroza, Noemi
Astocondor, Lizeth
Rondon, Claudia R
Ingelbeen, Brecht
Alpaca-Salvador, Hugo A
Amaro, Catherine
Aguado Ventura, Carla
Barco-Yaipén, Evelyn
Bocangel Fernandez, Cesar
Briones, Alexander
Burgos, Antonio
Campana, Rene
Castillo, Kelly
Castañeda-Sabogal, Alex
Coaquira, Angelica
Concha-Velasco, Fátima
Cuadros, Edwin Cuaresma
Chincha, Omayra
Diaz, Juan Carlos
Díaz Sipión, Roberto
Fernandez, Victor
Hueda-Zavaleta, Miguel
López, Enrique
Valera-Krumdieck, María
Vásquez, Rubén
Vidaurre Torres, Ana María
Villegas-Chiroque, Miguel
Sarmiento Lopez, Favio
Sullón Zavaleta, Pedro Alberto
Sierra Chavez, Elizett
Paricahua Peralta, Eduardo
Peralta Córdova, Teresa
Pino-Dueñas, Jimena Edith
Jacobs, Jan
description Surveillance of antimicrobial resistance among gram-negative bacteria (GNB) is of critical importance, but data for Peru are not available. To fill this gap, a non-interventional hospital-based surveillance study was conducted in 15 hospitals across Peru from July 2017 to October 2019. Consecutive unique blood culture isolates of key GNB (Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter spp.) recovered from hospitalized patients were collected for centralized antimicrobial susceptibility testing, along with linked epidemiological and clinical data. A total of 449 isolates were included in the analysis. Resistance to third-generation cephalosporins (3GCs) was present in 266 (59.2%) GNB isolates. Among E. coli (n = 199), 68.3% showed 3GC resistance (i.e., above the median ratio for low- and middle-income countries in 2020 for this sustainable development goal indicator). Carbapenem resistance was present in 74 (16.5%) GNB isolates, with wide variation among species (0% in E. coli, 11.0% in K. pneumoniae, 37.0% in P. aeruginosa, and 60.8% in Acinetobacter spp. isolates). Co-resistance to carbapenems and colistin was found in seven (1.6%) GNB isolates. Empiric treatment covered the causative GNB in 63.3% of 215 cases. The in-hospital case fatality ratio was 33.3% (92/276). Pseudomonas aeruginosa species and carbapenem resistance were associated with higher risk of in-hospital death. In conclusion, an important proportion of bloodstream infections in Peru are caused by highly resistant GNB and are associated with high in-hospital mortality.
doi_str_mv 10.4269/ajtmh.22-0556
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10622474</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2866379486</sourcerecordid><originalsourceid>FETCH-LOGICAL-c416t-f3c973d6506fd6117b895c746101d0388ef125470380b2c97f125fa9165ca42d3</originalsourceid><addsrcrecordid>eNpdkU1v1DAQhi0EokvhyBVZ4sIlxV-xEy5oW7VlpYquFsrV8jqT1qvELrazUn8Bf7sOLRVwmhnNM69m5kXoLSVHgsn2o9nl8eaIsYrUtXyGFlQoWVEp6udoQQhhVSu5OkCvUtoRQhtG6Ut0wJViTEq-QL_WEfZmAG8Bhx4vfXajszFsnRnwBpJL2cw95_F5NGP1Fa5NdnvAx8ZmiM7g4yGELuUIZsQr34PNLvg0D6whTtj4Di9TCtaZDB2-nLINI6RP-Mdqs1yfbq7wtzx1d6_Ri94MCd48xkN0dXb6_eRLdXF5vjpZXlRWUJmrnttW8U7WRPadpFRtm7a2SkhKaEd400BPWS1UScmWFXYue9NSWVsjWMcP0ecH3dtpO0JnwedoBn0b3WjinQ7G6X873t3o67DXlEjGhBJF4cOjQgw_J0hZjy5ZGAbjIUxJs6Y8VrWikQV9_x-6C1P05b5CNQ2vRS1IoaoHqrw9pQj90zaU6Nlj_dtjzZiePS78u79PeKL_mMrvAfNJo7E</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2888354540</pqid></control><display><type>article</type><title>Prevalence of Antimicrobial Resistance in Gram-Negative Bacteria Bloodstream Infections in Peru and Associated Outcomes: VIRAPERU Study</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Krapp, Fiorella ; García, Coralith ; Hinostroza, Noemi ; Astocondor, Lizeth ; Rondon, Claudia R ; Ingelbeen, Brecht ; Alpaca-Salvador, Hugo A ; Amaro, Catherine ; Aguado Ventura, Carla ; Barco-Yaipén, Evelyn ; Bocangel Fernandez, Cesar ; Briones, Alexander ; Burgos, Antonio ; Campana, Rene ; Castillo, Kelly ; Castañeda-Sabogal, Alex ; Coaquira, Angelica ; Concha-Velasco, Fátima ; Cuadros, Edwin Cuaresma ; Chincha, Omayra ; Diaz, Juan Carlos ; Díaz Sipión, Roberto ; Fernandez, Victor ; Hueda-Zavaleta, Miguel ; López, Enrique ; Valera-Krumdieck, María ; Vásquez, Rubén ; Vidaurre Torres, Ana María ; Villegas-Chiroque, Miguel ; Sarmiento Lopez, Favio ; Sullón Zavaleta, Pedro Alberto ; Sierra Chavez, Elizett ; Paricahua Peralta, Eduardo ; Peralta Córdova, Teresa ; Pino-Dueñas, Jimena Edith ; Jacobs, Jan</creator><creatorcontrib>Krapp, Fiorella ; García, Coralith ; Hinostroza, Noemi ; Astocondor, Lizeth ; Rondon, Claudia R ; Ingelbeen, Brecht ; Alpaca-Salvador, Hugo A ; Amaro, Catherine ; Aguado Ventura, Carla ; Barco-Yaipén, Evelyn ; Bocangel Fernandez, Cesar ; Briones, Alexander ; Burgos, Antonio ; Campana, Rene ; Castillo, Kelly ; Castañeda-Sabogal, Alex ; Coaquira, Angelica ; Concha-Velasco, Fátima ; Cuadros, Edwin Cuaresma ; Chincha, Omayra ; Diaz, Juan Carlos ; Díaz Sipión, Roberto ; Fernandez, Victor ; Hueda-Zavaleta, Miguel ; López, Enrique ; Valera-Krumdieck, María ; Vásquez, Rubén ; Vidaurre Torres, Ana María ; Villegas-Chiroque, Miguel ; Sarmiento Lopez, Favio ; Sullón Zavaleta, Pedro Alberto ; Sierra Chavez, Elizett ; Paricahua Peralta, Eduardo ; Peralta Córdova, Teresa ; Pino-Dueñas, Jimena Edith ; Jacobs, Jan</creatorcontrib><description>Surveillance of antimicrobial resistance among gram-negative bacteria (GNB) is of critical importance, but data for Peru are not available. To fill this gap, a non-interventional hospital-based surveillance study was conducted in 15 hospitals across Peru from July 2017 to October 2019. Consecutive unique blood culture isolates of key GNB (Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter spp.) recovered from hospitalized patients were collected for centralized antimicrobial susceptibility testing, along with linked epidemiological and clinical data. A total of 449 isolates were included in the analysis. Resistance to third-generation cephalosporins (3GCs) was present in 266 (59.2%) GNB isolates. Among E. coli (n = 199), 68.3% showed 3GC resistance (i.e., above the median ratio for low- and middle-income countries in 2020 for this sustainable development goal indicator). Carbapenem resistance was present in 74 (16.5%) GNB isolates, with wide variation among species (0% in E. coli, 11.0% in K. pneumoniae, 37.0% in P. aeruginosa, and 60.8% in Acinetobacter spp. isolates). Co-resistance to carbapenems and colistin was found in seven (1.6%) GNB isolates. Empiric treatment covered the causative GNB in 63.3% of 215 cases. The in-hospital case fatality ratio was 33.3% (92/276). Pseudomonas aeruginosa species and carbapenem resistance were associated with higher risk of in-hospital death. In conclusion, an important proportion of bloodstream infections in Peru are caused by highly resistant GNB and are associated with high in-hospital mortality.</description><identifier>ISSN: 0002-9637</identifier><identifier>EISSN: 1476-1645</identifier><identifier>DOI: 10.4269/ajtmh.22-0556</identifier><identifier>PMID: 37722663</identifier><language>eng</language><publisher>United States: Institute of Tropical Medicine</publisher><subject>Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Antimicrobial agents ; Carbapenems ; Drug resistance ; Drug Resistance, Bacterial ; E coli ; Escherichia coli ; Gram-Negative Bacteria ; Gram-Negative Bacterial Infections - drug therapy ; Gram-Negative Bacterial Infections - epidemiology ; Gram-Negative Bacterial Infections - microbiology ; Hospital Mortality ; Humans ; Klebsiella pneumoniae ; Microbial Sensitivity Tests ; Peru - epidemiology ; Prevalence ; Pseudomonas aeruginosa ; Sepsis - drug therapy ; Surveillance</subject><ispartof>The American journal of tropical medicine and hygiene, 2023-11, Vol.109 (5), p.1095-1106</ispartof><rights>Copyright Institute of Tropical Medicine Nov 2023</rights><rights>The author(s) 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c416t-f3c973d6506fd6117b895c746101d0388ef125470380b2c97f125fa9165ca42d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622474/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622474/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37722663$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Krapp, Fiorella</creatorcontrib><creatorcontrib>García, Coralith</creatorcontrib><creatorcontrib>Hinostroza, Noemi</creatorcontrib><creatorcontrib>Astocondor, Lizeth</creatorcontrib><creatorcontrib>Rondon, Claudia R</creatorcontrib><creatorcontrib>Ingelbeen, Brecht</creatorcontrib><creatorcontrib>Alpaca-Salvador, Hugo A</creatorcontrib><creatorcontrib>Amaro, Catherine</creatorcontrib><creatorcontrib>Aguado Ventura, Carla</creatorcontrib><creatorcontrib>Barco-Yaipén, Evelyn</creatorcontrib><creatorcontrib>Bocangel Fernandez, Cesar</creatorcontrib><creatorcontrib>Briones, Alexander</creatorcontrib><creatorcontrib>Burgos, Antonio</creatorcontrib><creatorcontrib>Campana, Rene</creatorcontrib><creatorcontrib>Castillo, Kelly</creatorcontrib><creatorcontrib>Castañeda-Sabogal, Alex</creatorcontrib><creatorcontrib>Coaquira, Angelica</creatorcontrib><creatorcontrib>Concha-Velasco, Fátima</creatorcontrib><creatorcontrib>Cuadros, Edwin Cuaresma</creatorcontrib><creatorcontrib>Chincha, Omayra</creatorcontrib><creatorcontrib>Diaz, Juan Carlos</creatorcontrib><creatorcontrib>Díaz Sipión, Roberto</creatorcontrib><creatorcontrib>Fernandez, Victor</creatorcontrib><creatorcontrib>Hueda-Zavaleta, Miguel</creatorcontrib><creatorcontrib>López, Enrique</creatorcontrib><creatorcontrib>Valera-Krumdieck, María</creatorcontrib><creatorcontrib>Vásquez, Rubén</creatorcontrib><creatorcontrib>Vidaurre Torres, Ana María</creatorcontrib><creatorcontrib>Villegas-Chiroque, Miguel</creatorcontrib><creatorcontrib>Sarmiento Lopez, Favio</creatorcontrib><creatorcontrib>Sullón Zavaleta, Pedro Alberto</creatorcontrib><creatorcontrib>Sierra Chavez, Elizett</creatorcontrib><creatorcontrib>Paricahua Peralta, Eduardo</creatorcontrib><creatorcontrib>Peralta Córdova, Teresa</creatorcontrib><creatorcontrib>Pino-Dueñas, Jimena Edith</creatorcontrib><creatorcontrib>Jacobs, Jan</creatorcontrib><title>Prevalence of Antimicrobial Resistance in Gram-Negative Bacteria Bloodstream Infections in Peru and Associated Outcomes: VIRAPERU Study</title><title>The American journal of tropical medicine and hygiene</title><addtitle>Am J Trop Med Hyg</addtitle><description>Surveillance of antimicrobial resistance among gram-negative bacteria (GNB) is of critical importance, but data for Peru are not available. To fill this gap, a non-interventional hospital-based surveillance study was conducted in 15 hospitals across Peru from July 2017 to October 2019. Consecutive unique blood culture isolates of key GNB (Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter spp.) recovered from hospitalized patients were collected for centralized antimicrobial susceptibility testing, along with linked epidemiological and clinical data. A total of 449 isolates were included in the analysis. Resistance to third-generation cephalosporins (3GCs) was present in 266 (59.2%) GNB isolates. Among E. coli (n = 199), 68.3% showed 3GC resistance (i.e., above the median ratio for low- and middle-income countries in 2020 for this sustainable development goal indicator). Carbapenem resistance was present in 74 (16.5%) GNB isolates, with wide variation among species (0% in E. coli, 11.0% in K. pneumoniae, 37.0% in P. aeruginosa, and 60.8% in Acinetobacter spp. isolates). Co-resistance to carbapenems and colistin was found in seven (1.6%) GNB isolates. Empiric treatment covered the causative GNB in 63.3% of 215 cases. The in-hospital case fatality ratio was 33.3% (92/276). Pseudomonas aeruginosa species and carbapenem resistance were associated with higher risk of in-hospital death. In conclusion, an important proportion of bloodstream infections in Peru are caused by highly resistant GNB and are associated with high in-hospital mortality.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antimicrobial agents</subject><subject>Carbapenems</subject><subject>Drug resistance</subject><subject>Drug Resistance, Bacterial</subject><subject>E coli</subject><subject>Escherichia coli</subject><subject>Gram-Negative Bacteria</subject><subject>Gram-Negative Bacterial Infections - drug therapy</subject><subject>Gram-Negative Bacterial Infections - epidemiology</subject><subject>Gram-Negative Bacterial Infections - microbiology</subject><subject>Hospital Mortality</subject><subject>Humans</subject><subject>Klebsiella pneumoniae</subject><subject>Microbial Sensitivity Tests</subject><subject>Peru - epidemiology</subject><subject>Prevalence</subject><subject>Pseudomonas aeruginosa</subject><subject>Sepsis - drug therapy</subject><subject>Surveillance</subject><issn>0002-9637</issn><issn>1476-1645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkU1v1DAQhi0EokvhyBVZ4sIlxV-xEy5oW7VlpYquFsrV8jqT1qvELrazUn8Bf7sOLRVwmhnNM69m5kXoLSVHgsn2o9nl8eaIsYrUtXyGFlQoWVEp6udoQQhhVSu5OkCvUtoRQhtG6Ut0wJViTEq-QL_WEfZmAG8Bhx4vfXajszFsnRnwBpJL2cw95_F5NGP1Fa5NdnvAx8ZmiM7g4yGELuUIZsQr34PNLvg0D6whTtj4Di9TCtaZDB2-nLINI6RP-Mdqs1yfbq7wtzx1d6_Ri94MCd48xkN0dXb6_eRLdXF5vjpZXlRWUJmrnttW8U7WRPadpFRtm7a2SkhKaEd400BPWS1UScmWFXYue9NSWVsjWMcP0ecH3dtpO0JnwedoBn0b3WjinQ7G6X873t3o67DXlEjGhBJF4cOjQgw_J0hZjy5ZGAbjIUxJs6Y8VrWikQV9_x-6C1P05b5CNQ2vRS1IoaoHqrw9pQj90zaU6Nlj_dtjzZiePS78u79PeKL_mMrvAfNJo7E</recordid><startdate>20231101</startdate><enddate>20231101</enddate><creator>Krapp, Fiorella</creator><creator>García, Coralith</creator><creator>Hinostroza, Noemi</creator><creator>Astocondor, Lizeth</creator><creator>Rondon, Claudia R</creator><creator>Ingelbeen, Brecht</creator><creator>Alpaca-Salvador, Hugo A</creator><creator>Amaro, Catherine</creator><creator>Aguado Ventura, Carla</creator><creator>Barco-Yaipén, Evelyn</creator><creator>Bocangel Fernandez, Cesar</creator><creator>Briones, Alexander</creator><creator>Burgos, Antonio</creator><creator>Campana, Rene</creator><creator>Castillo, Kelly</creator><creator>Castañeda-Sabogal, Alex</creator><creator>Coaquira, Angelica</creator><creator>Concha-Velasco, Fátima</creator><creator>Cuadros, Edwin Cuaresma</creator><creator>Chincha, Omayra</creator><creator>Diaz, Juan Carlos</creator><creator>Díaz Sipión, Roberto</creator><creator>Fernandez, Victor</creator><creator>Hueda-Zavaleta, Miguel</creator><creator>López, Enrique</creator><creator>Valera-Krumdieck, María</creator><creator>Vásquez, Rubén</creator><creator>Vidaurre Torres, Ana María</creator><creator>Villegas-Chiroque, Miguel</creator><creator>Sarmiento Lopez, Favio</creator><creator>Sullón Zavaleta, Pedro Alberto</creator><creator>Sierra Chavez, Elizett</creator><creator>Paricahua Peralta, Eduardo</creator><creator>Peralta Córdova, Teresa</creator><creator>Pino-Dueñas, Jimena Edith</creator><creator>Jacobs, Jan</creator><general>Institute of Tropical Medicine</general><general>The American Society of Tropical Medicine and Hygiene</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20231101</creationdate><title>Prevalence of Antimicrobial Resistance in Gram-Negative Bacteria Bloodstream Infections in Peru and Associated Outcomes: VIRAPERU Study</title><author>Krapp, Fiorella ; García, Coralith ; Hinostroza, Noemi ; Astocondor, Lizeth ; Rondon, Claudia R ; Ingelbeen, Brecht ; Alpaca-Salvador, Hugo A ; Amaro, Catherine ; Aguado Ventura, Carla ; Barco-Yaipén, Evelyn ; Bocangel Fernandez, Cesar ; Briones, Alexander ; Burgos, Antonio ; Campana, Rene ; Castillo, Kelly ; Castañeda-Sabogal, Alex ; Coaquira, Angelica ; Concha-Velasco, Fátima ; Cuadros, Edwin Cuaresma ; Chincha, Omayra ; Diaz, Juan Carlos ; Díaz Sipión, Roberto ; Fernandez, Victor ; Hueda-Zavaleta, Miguel ; López, Enrique ; Valera-Krumdieck, María ; Vásquez, Rubén ; Vidaurre Torres, Ana María ; Villegas-Chiroque, Miguel ; Sarmiento Lopez, Favio ; Sullón Zavaleta, Pedro Alberto ; Sierra Chavez, Elizett ; Paricahua Peralta, Eduardo ; Peralta Córdova, Teresa ; Pino-Dueñas, Jimena Edith ; Jacobs, Jan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c416t-f3c973d6506fd6117b895c746101d0388ef125470380b2c97f125fa9165ca42d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antimicrobial agents</topic><topic>Carbapenems</topic><topic>Drug resistance</topic><topic>Drug Resistance, Bacterial</topic><topic>E coli</topic><topic>Escherichia coli</topic><topic>Gram-Negative Bacteria</topic><topic>Gram-Negative Bacterial Infections - drug therapy</topic><topic>Gram-Negative Bacterial Infections - epidemiology</topic><topic>Gram-Negative Bacterial Infections - microbiology</topic><topic>Hospital Mortality</topic><topic>Humans</topic><topic>Klebsiella pneumoniae</topic><topic>Microbial Sensitivity Tests</topic><topic>Peru - epidemiology</topic><topic>Prevalence</topic><topic>Pseudomonas aeruginosa</topic><topic>Sepsis - drug therapy</topic><topic>Surveillance</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Krapp, Fiorella</creatorcontrib><creatorcontrib>García, Coralith</creatorcontrib><creatorcontrib>Hinostroza, Noemi</creatorcontrib><creatorcontrib>Astocondor, Lizeth</creatorcontrib><creatorcontrib>Rondon, Claudia R</creatorcontrib><creatorcontrib>Ingelbeen, Brecht</creatorcontrib><creatorcontrib>Alpaca-Salvador, Hugo A</creatorcontrib><creatorcontrib>Amaro, Catherine</creatorcontrib><creatorcontrib>Aguado Ventura, Carla</creatorcontrib><creatorcontrib>Barco-Yaipén, Evelyn</creatorcontrib><creatorcontrib>Bocangel Fernandez, Cesar</creatorcontrib><creatorcontrib>Briones, Alexander</creatorcontrib><creatorcontrib>Burgos, Antonio</creatorcontrib><creatorcontrib>Campana, Rene</creatorcontrib><creatorcontrib>Castillo, Kelly</creatorcontrib><creatorcontrib>Castañeda-Sabogal, Alex</creatorcontrib><creatorcontrib>Coaquira, Angelica</creatorcontrib><creatorcontrib>Concha-Velasco, Fátima</creatorcontrib><creatorcontrib>Cuadros, Edwin Cuaresma</creatorcontrib><creatorcontrib>Chincha, Omayra</creatorcontrib><creatorcontrib>Diaz, Juan Carlos</creatorcontrib><creatorcontrib>Díaz Sipión, Roberto</creatorcontrib><creatorcontrib>Fernandez, Victor</creatorcontrib><creatorcontrib>Hueda-Zavaleta, Miguel</creatorcontrib><creatorcontrib>López, Enrique</creatorcontrib><creatorcontrib>Valera-Krumdieck, María</creatorcontrib><creatorcontrib>Vásquez, Rubén</creatorcontrib><creatorcontrib>Vidaurre Torres, Ana María</creatorcontrib><creatorcontrib>Villegas-Chiroque, Miguel</creatorcontrib><creatorcontrib>Sarmiento Lopez, Favio</creatorcontrib><creatorcontrib>Sullón Zavaleta, Pedro Alberto</creatorcontrib><creatorcontrib>Sierra Chavez, Elizett</creatorcontrib><creatorcontrib>Paricahua Peralta, Eduardo</creatorcontrib><creatorcontrib>Peralta Córdova, Teresa</creatorcontrib><creatorcontrib>Pino-Dueñas, Jimena Edith</creatorcontrib><creatorcontrib>Jacobs, Jan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The American journal of tropical medicine and hygiene</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Krapp, Fiorella</au><au>García, Coralith</au><au>Hinostroza, Noemi</au><au>Astocondor, Lizeth</au><au>Rondon, Claudia R</au><au>Ingelbeen, Brecht</au><au>Alpaca-Salvador, Hugo A</au><au>Amaro, Catherine</au><au>Aguado Ventura, Carla</au><au>Barco-Yaipén, Evelyn</au><au>Bocangel Fernandez, Cesar</au><au>Briones, Alexander</au><au>Burgos, Antonio</au><au>Campana, Rene</au><au>Castillo, Kelly</au><au>Castañeda-Sabogal, Alex</au><au>Coaquira, Angelica</au><au>Concha-Velasco, Fátima</au><au>Cuadros, Edwin Cuaresma</au><au>Chincha, Omayra</au><au>Diaz, Juan Carlos</au><au>Díaz Sipión, Roberto</au><au>Fernandez, Victor</au><au>Hueda-Zavaleta, Miguel</au><au>López, Enrique</au><au>Valera-Krumdieck, María</au><au>Vásquez, Rubén</au><au>Vidaurre Torres, Ana María</au><au>Villegas-Chiroque, Miguel</au><au>Sarmiento Lopez, Favio</au><au>Sullón Zavaleta, Pedro Alberto</au><au>Sierra Chavez, Elizett</au><au>Paricahua Peralta, Eduardo</au><au>Peralta Córdova, Teresa</au><au>Pino-Dueñas, Jimena Edith</au><au>Jacobs, Jan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of Antimicrobial Resistance in Gram-Negative Bacteria Bloodstream Infections in Peru and Associated Outcomes: VIRAPERU Study</atitle><jtitle>The American journal of tropical medicine and hygiene</jtitle><addtitle>Am J Trop Med Hyg</addtitle><date>2023-11-01</date><risdate>2023</risdate><volume>109</volume><issue>5</issue><spage>1095</spage><epage>1106</epage><pages>1095-1106</pages><issn>0002-9637</issn><eissn>1476-1645</eissn><abstract>Surveillance of antimicrobial resistance among gram-negative bacteria (GNB) is of critical importance, but data for Peru are not available. To fill this gap, a non-interventional hospital-based surveillance study was conducted in 15 hospitals across Peru from July 2017 to October 2019. Consecutive unique blood culture isolates of key GNB (Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter spp.) recovered from hospitalized patients were collected for centralized antimicrobial susceptibility testing, along with linked epidemiological and clinical data. A total of 449 isolates were included in the analysis. Resistance to third-generation cephalosporins (3GCs) was present in 266 (59.2%) GNB isolates. Among E. coli (n = 199), 68.3% showed 3GC resistance (i.e., above the median ratio for low- and middle-income countries in 2020 for this sustainable development goal indicator). Carbapenem resistance was present in 74 (16.5%) GNB isolates, with wide variation among species (0% in E. coli, 11.0% in K. pneumoniae, 37.0% in P. aeruginosa, and 60.8% in Acinetobacter spp. isolates). Co-resistance to carbapenems and colistin was found in seven (1.6%) GNB isolates. Empiric treatment covered the causative GNB in 63.3% of 215 cases. The in-hospital case fatality ratio was 33.3% (92/276). Pseudomonas aeruginosa species and carbapenem resistance were associated with higher risk of in-hospital death. In conclusion, an important proportion of bloodstream infections in Peru are caused by highly resistant GNB and are associated with high in-hospital mortality.</abstract><cop>United States</cop><pub>Institute of Tropical Medicine</pub><pmid>37722663</pmid><doi>10.4269/ajtmh.22-0556</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0002-9637
ispartof The American journal of tropical medicine and hygiene, 2023-11, Vol.109 (5), p.1095-1106
issn 0002-9637
1476-1645
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10622474
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects Anti-Bacterial Agents - pharmacology
Anti-Bacterial Agents - therapeutic use
Antimicrobial agents
Carbapenems
Drug resistance
Drug Resistance, Bacterial
E coli
Escherichia coli
Gram-Negative Bacteria
Gram-Negative Bacterial Infections - drug therapy
Gram-Negative Bacterial Infections - epidemiology
Gram-Negative Bacterial Infections - microbiology
Hospital Mortality
Humans
Klebsiella pneumoniae
Microbial Sensitivity Tests
Peru - epidemiology
Prevalence
Pseudomonas aeruginosa
Sepsis - drug therapy
Surveillance
title Prevalence of Antimicrobial Resistance in Gram-Negative Bacteria Bloodstream Infections in Peru and Associated Outcomes: VIRAPERU Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T06%3A47%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20Antimicrobial%20Resistance%20in%20Gram-Negative%20Bacteria%20Bloodstream%20Infections%20in%20Peru%20and%20Associated%20Outcomes:%20VIRAPERU%20Study&rft.jtitle=The%20American%20journal%20of%20tropical%20medicine%20and%20hygiene&rft.au=Krapp,%20Fiorella&rft.date=2023-11-01&rft.volume=109&rft.issue=5&rft.spage=1095&rft.epage=1106&rft.pages=1095-1106&rft.issn=0002-9637&rft.eissn=1476-1645&rft_id=info:doi/10.4269/ajtmh.22-0556&rft_dat=%3Cproquest_pubme%3E2866379486%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2888354540&rft_id=info:pmid/37722663&rfr_iscdi=true